We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+8.94%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$76.2B
AUM Growth
+$2.6B
(+3.5%)
Cap. Flow
-$2.97B
Cap. Flow
% of AUM
-3.9%
Top 10 Holdings %
Top 10 Hldgs %
21.61%
Holding
3,238
New
235
Increased
684
Reduced
2,065
Closed
243
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$77.3M |
| 2 |
Blackstone
BX
|
+$53.2M |
| 3 |
NXP Semiconductors
NXPI
|
+$40.8M |
| 4 |
Palantir
PLTR
|
+$34.3M |
| 5 |
Snowflake
SNOW
|
+$24.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$206M |
| 2 |
Microsoft
MSFT
|
+$163M |
| 3 |
Linde
LIN
|
+$133M |
| 4 |
Amazon
AMZN
|
+$94.7M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$82.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.34% |
| 2 | Financials | 14.16% |
| 3 | Healthcare | 12.95% |
| 4 | Consumer Discretionary | 12.06% |
| 5 | Communication Services | 9.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ITIC
2751
Investors Title Co
ITIC
$550M
| $329K | ﹤0.01% |
1,885
-222
| -11% | -$38.6K |
|
2752
Viemed Healthcare
VMD
$365M
| $329K | ﹤0.01% |
46,052
+9,109
| +25% | +$78.9K |
|
2753
Preformed Line Products
PLPC
$2.26B
| $328K | ﹤0.01% |
4,419
-518
| -10% | -$37.3K |
|
2754
TETRA Technologies
TTI
$1.27B
| $328K | ﹤0.01% |
+75,531
| New | +$249K |
|
|
EIGR
2755
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
| $328K | ﹤0.01% |
1,282
+399
| +45% | +$99.6K |
|
|
MILE
2756
DELISTED
Metromile, Inc. Common Stock
MILE
| $326K | ﹤0.01% |
+35,624
| New | +$319K |
|
|
RMO
2757
DELISTED
Romeo Power, Inc.
RMO
| $325K | ﹤0.01% |
+39,983
| New | +$341K |
|
2758
Nuvation Bio
NUVB
$2.31B
| $323K | ﹤0.01% |
+34,647
| New | +$395K |
|
2759
Airbnb
ABNB
$104B
| $321K | ﹤0.01% |
2,096
-11
| -0.5% | -$1.73K |
|
2760
Ceco Environmental
CECO
$4.01B
| $321K | ﹤0.01% |
44,864
-5,168
| -10% | -$40K |
|
2761
Lineage Cell Therapeutics
LCTX
$282M
| $321K | ﹤0.01% |
+112,515
| New | +$291K |
|
2762
Orrstown Financial Services
ORRF
$839M
| $321K | ﹤0.01% |
13,921
-1,648
| -11% | -$39.8K |
|
2763
Distribution Solutions Group
DSGR
$1.61B
| $320K | ﹤0.01% |
11,962
-2,478
| -17% | -$68.4K |
|
|
GSKY
2764
DELISTED
GreenSky, Inc. Class A Common Stock
GSKY
| $320K | ﹤0.01% |
57,587
-192
| -0.3% | -$1.15K |
|
2765
Tiptree Inc
TIPT
$665M
| $318K | ﹤0.01% |
34,143
-6,825
| -17% | -$72K |
|
2766
DarioHealth
DRIO
$75.9M
| $314K | ﹤0.01% |
+734
| New | +$279K |
|
2767
Beam Global
BEEM
$25.8M
| $313K | ﹤0.01% |
+8,159
| New | +$269K |
|
|
PFBI
2768
DELISTED
Premier Financial Bancorp
PFBI
| $312K | ﹤0.01% |
18,529
-2,880
| -13% | -$53.3K |
|
|
BRT
2769
BRT Apartments
BRT
$271M
| $311K | ﹤0.01% |
17,907
-1,148
| -6% | -$20.5K |
|
|
EVLO
2770
DELISTED
Evelo Biosciences, Inc. Common Stock
EVLO
| $311K | ﹤0.01% |
1,131
+151
| +15% | +$38.1K |
|
2771
Cogent Biosciences
COGT
$7.27B
| $310K | ﹤0.01% |
+38,280
| New | +$323K |
|
2772
Playboy Inc
PLBY
$138M
| $310K | ﹤0.01% |
+7,977
| New | +$336K |
|
2773
Spok Holdings
SPOK
$236M
| $310K | ﹤0.01% |
32,241
-29,318
| -48% | -$313K |
|
2774
Instil Bio
TIL
$49.4M
| $310K | ﹤0.01% |
+802
| New | +$297K |
|
2775
Safe Bulkers
SB
$778M
| $309K | ﹤0.01% |
77,058
-4,663
| -6% | -$16.3K |
|
Similar funds
VAM
RhumbLine Advisers's Q2 2021 Portfolio in Review
As of Q2 2021, RhumbLine Advisers held 3,238 positions worth $76.2B, up 3.5% from $73.6B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
RhumbLine Advisers withdrew a net $2.97B in Q2 2021, closing 243 positions and reducing 2,065 holdings. Its most notable exit was Varian Medical Systems, Inc., an estimated $32.1M position sold in full.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 23% a quarter earlier, followed by Financials and Healthcare.
Against the trend, RhumbLine Advisers opened a new position in DraftKings worth $14.2M.
- RhumbLine Advisers's largest Q2 2021 buy was DraftKings: 271,227 shares worth $14.2M.
- RhumbLine Advisers added most to iShares Core S&P 500 ETF in Q2 2021, an estimated $77.3M increase.
- RhumbLine Advisers's biggest Q2 2021 reduction was Apple, cutting an estimated $206M.
- RhumbLine Advisers fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $32.1M.
- RhumbLine Advisers's ten largest holdings make up 22% of its $76.2B portfolio in Q2 2021.
- RhumbLine Advisers opened 235 new positions and closed 243 in Q2 2021.
- RhumbLine Advisers's portfolio value rose 3.5% quarter-over-quarter to $76.2B.
Based on RhumbLine Advisers's 13F filing for Q2 2021, filed 5 Aug 2021.